Valerie S Calvert

Valerie S Calvert

UNVERIFIED PROFILE

Are you Valerie S Calvert?   Register this Author

Register author
Valerie S Calvert

Valerie S Calvert

Publications by authors named "Valerie S Calvert"

Are you Valerie S Calvert?   Register this Author

22Publications

508Reads

48Profile Views

Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.

Cancer Prev Res (Phila) 2016 Mar 22;9(3):215-24. Epub 2016 Jan 22.

The University of Arizona Cancer Center, Tucson, Arizona. Department of Medicine, The University of Arizona, Tucson, Arizona. Department of Cellular and Molecular Medicine, The University of Arizona, Tucson, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777684PMC
March 2016

Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.

Clin Cancer Res 2013 Mar 5;19(6):1433-44. Epub 2013 Feb 5.

Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602223PMC
March 2013

Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis.

J Proteome Res 2010 Jun;9(6):3218-24

Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Virginia 22042, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr100069eDOI Listing
June 2010

Reverse phase protein microarrays for theranostics and patient-tailored therapy.

Methods Mol Biol 2008 ;441:113-28

Laboratory of Pathology, National Cancer Institute, Center for Cancer Research, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-60327-047-2_8DOI Listing
May 2008

Laser-capture microdissection.

Nat Protoc 2006 ;1(2):586-603

Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Blvd. MS 4E3, Manassas, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nprot.2006.85DOI Listing
September 2007

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

J Clin Oncol 2005 May;23(15):3614-21

US Food and Drug Administration-National Cancer Institute Clinical Proteomics Program, Office of Cellular and Gene Therapy, Center for Biologics Evaluation and Research, FDA, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.509DOI Listing
May 2005

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

Mol Cell Proteomics 2005 Apr 25;4(4):346-55. Epub 2005 Jan 25.

United States Food and Drug Administration (FDA)-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.mcponline.org/lookup/doi/10.1074/mcp.T500003-MCP2
Publisher Site
http://dx.doi.org/10.1074/mcp.T500003-MCP200DOI Listing
April 2005

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays.

Proteomics 2003 Nov;3(11):2085-90

Center for Cancer Research, National Cancer Institute/NIH, Building 29A/Room 2B20, 8000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200300591DOI Listing
November 2003